State Board Of Administration Of Florida Retirement System Lineage Cell Therapeutics, Inc. Transaction History

State Board Of Administration Of Florida Retirement System

  • $51.5 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023
BUY
$1.16 - $1.53 $394 - $520
340 Added 0.93%
36,970 $43,000
Q2 2023

Aug 11, 2023
BUY
$1.26 - $1.53 $46,153 - $56,043
36,630 New
36,630 $51,000
Q2 2020

Aug 07, 2020
SELL
$0.71 - $1.18 $15,722 - $26,129
-22,144 Closed
0 $0
Q1 2020

May 05, 2020
SELL
$0.6 - $1.58 $384 - $1,011
-640 Reduced 2.81%
22,144 $18,000
Q3 2019

Nov 07, 2019
BUY
$0.85 - $1.24 $19,366 - $28,252
22,784 New
22,784 $22,000

Others Institutions Holding LCTX

# of Institutions
121
Shares Held
94.2M
Call Options Held
63.8K
Put Options Held
1K
View Full List

About Lineage Cell Therapeutics, Inc.

LCTX Quotes by TradingView
  • Ticker LCTX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 169,755,008
  • Market Cap $96.8M
  • Description
  • Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...
More about LCTX
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email